Vimarsana
Biggest News Aggregation in the World

Page 3 - Stephen Gunstream News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Stephen Gunstream. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Stephen Gunstream Today - Breaking & Trending Today

Teknova Reports Second Quarter 2023 Financial Results - Vimarsana News

Teknova Reports Second Quarter 2023 Financial Results

Second quarter 2023 total revenue was $11.5 million, up 26% sequentiallyReceived certification of new state-of-the-art facility for production of ...

Teknova Expands Proprietary AAV-Tek™ Solutions Product Line to Deliver End-to-End Solutions for ... - Vimarsana News

Teknova Expands Proprietary AAV-Tek™ Solutions Product Line to Deliver End-to-End Solutions for ...

HOLLISTER, Calif., July 11, 2023 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents for the research, discovery, development, and commercialization of novel therapies,

Alpha Teknova, Inc. (NASDAQ:TKNO) Q4 2022 Earnings Call Transcript - Vimarsana News

Alpha Teknova, Inc. (NASDAQ:TKNO) Q4 2022 Earnings Call Transcript

Operator: Thank you for standing by, and welcome to Teknova's Fourth Quarter and Full Year 2022 Financial Results Call. At this time, all participants are in a listen-only mode.

Teknova and Sartorius BIA Separations Collaborate on Gene Therapy Process Development - Vimarsana News

Teknova and Sartorius BIA Separations Collaborate on Gene Therapy Process Development

Teknova and Sartorius BIA Separations plan to continue developing data to show improvements in AAV purification when using their combined methods.

Teknova to Participate in Upcoming Investor Conferences - Vimarsana News

Teknova to Participate in Upcoming Investor Conferences

HOLLISTER, Calif., Feb. 10, 2023 -- Alpha Teknova, Inc. , a leading producer of critical reagents for the research, discovery, development, and commercialization of novel therapies, vaccines, and... | February 10, 2023